Christopher R. Stone

Array ( [id] => 9971241 [patent_doc_number] => 09018251 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-28 [patent_title] => 'Method for treating brain cancer or reducing temozolomide-resistance of brain cancer cells' [patent_app_type] => utility [patent_app_number] => 13/109619 [patent_app_country] => US [patent_app_date] => 2011-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 7366 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13109619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8496470 [patent_doc_number] => 20120295878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'METHOD FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/109128 [patent_app_country] => US [patent_app_date] => 2011-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12745 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13109128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6015698 [patent_doc_number] => 20110223619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'COMBINATIONS OF PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND CHEMOTHERAPEUTIC AGENTS, AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/109670 [patent_app_country] => US [patent_app_date] => 2011-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 57 [patent_no_of_words] => 47184 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20110223619.pdf [firstpage_image] =>[orig_patent_app_number] => 13109670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8489147 [patent_doc_number] => 20120288554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'CANFOSFAMIDE MONOTHERAPY FOR TREATING MULTIPLE MYELOMA' [patent_app_type] => utility [patent_app_number] => 13/106702 [patent_app_country] => US [patent_app_date] => 2011-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4359 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13106702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8128545 [patent_doc_number] => 20120088822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'LOW-DOSE DOXEPIN FOR TREATMENT OF SLEEP DISORDERS IN ELDERLY PATIENTS' [patent_app_type] => utility [patent_app_number] => 13/102985 [patent_app_country] => US [patent_app_date] => 2011-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12845 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20120088822.pdf [firstpage_image] =>[orig_patent_app_number] => 13102985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574196 [patent_doc_number] => 20110269852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'METHODS AND MECHANISMS INVOLVING HYPERPIGMENTATION PARTICULARLY FOR AFRICAN AMERICAN SKIN' [patent_app_type] => utility [patent_app_number] => 13/099290 [patent_app_country] => US [patent_app_date] => 2011-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4919 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269852.pdf [firstpage_image] =>[orig_patent_app_number] => 13099290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7808075 [patent_doc_number] => 20120059029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'SELECTIVE INTEGRIN INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/098538 [patent_app_country] => US [patent_app_date] => 2011-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13688 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20120059029.pdf [firstpage_image] =>[orig_patent_app_number] => 13098538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064347 [patent_doc_number] => 20110201618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'KMUPS INHIBITING PROLIFERATION AND OBLITERATION OF PULMONARY ARTERY' [patent_app_type] => utility [patent_app_number] => 13/095393 [patent_app_country] => US [patent_app_date] => 2011-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10325 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201618.pdf [firstpage_image] =>[orig_patent_app_number] => 13095393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064422 [patent_doc_number] => 20110201653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'METHOD FOR INHIBITING AND/OR PREVENTING FORMATION OF CANCER METASTASES AND SECONDARY MALIGNANT CANCER' [patent_app_type] => utility [patent_app_number] => 13/094575 [patent_app_country] => US [patent_app_date] => 2011-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4508 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201653.pdf [firstpage_image] =>[orig_patent_app_number] => 13094575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7499704 [patent_doc_number] => 20110262561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'Protoilludance Norsesquiterpenoid Esters and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/093080 [patent_app_country] => US [patent_app_date] => 2011-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10499 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262561.pdf [firstpage_image] =>[orig_patent_app_number] => 13093080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7502023 [patent_doc_number] => 20110263697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'Methods of Reducing Oxidative Modification of a Muscle Cell Protein' [patent_app_type] => utility [patent_app_number] => 13/092199 [patent_app_country] => US [patent_app_date] => 2011-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12731 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263697.pdf [firstpage_image] =>[orig_patent_app_number] => 13092199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8638186 [patent_doc_number] => 20130029989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'TOPICAL TREATMENTS FOR PAIN' [patent_app_type] => utility [patent_app_number] => 13/640069 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12835 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13640069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511563 [patent_doc_number] => 20110257273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'POLYESTER RESIN AND PURPOSES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/084127 [patent_app_country] => US [patent_app_date] => 2011-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18918 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257273.pdf [firstpage_image] =>[orig_patent_app_number] => 13084127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9995908 [patent_doc_number] => 09040506 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-26 [patent_title] => '7,11-methanocycloocta [B] quinoline derivative as highly functionalizable acetylcholinesterase inhibitors' [patent_app_type] => utility [patent_app_number] => 13/640182 [patent_app_country] => US [patent_app_date] => 2011-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29710 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13640182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696142 [patent_doc_number] => 20110230448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'Treatment and/or Prevention of Non-Viral Epithelial Damage' [patent_app_type] => utility [patent_app_number] => 13/073605 [patent_app_country] => US [patent_app_date] => 2011-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15196 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20110230448.pdf [firstpage_image] =>[orig_patent_app_number] => 13073605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10025091 [patent_doc_number] => 09066970 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-30 [patent_title] => 'Pharmaceutical compositions containing substituted 6-deoxy-6-sulfanylcyclodextrin' [patent_app_type] => utility [patent_app_number] => 13/635287 [patent_app_country] => US [patent_app_date] => 2011-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9393 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13635287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8649628 [patent_doc_number] => 20130035358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-07 [patent_title] => 'Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/634221 [patent_app_country] => US [patent_app_date] => 2011-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32550 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13634221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6014823 [patent_doc_number] => 20110223157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'METHODS FOR THE TREATMENT OF NON-HODGKIN\'S LYMPHOMAS USING LENALIDOMIDE, AND GENE AND PROTEIN BIOMARKERS AS A PREDICTOR' [patent_app_type] => utility [patent_app_number] => 13/046527 [patent_app_country] => US [patent_app_date] => 2011-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20685 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20110223157.pdf [firstpage_image] =>[orig_patent_app_number] => 13046527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8510416 [patent_doc_number] => 20120309824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-06 [patent_title] => 'AZEOTROPIC AND AZEOTROPE-LIKE COMPOSITIONS OF E-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE AND ETHYLENE OXIDE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/574802 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4605 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13574802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8201102 [patent_doc_number] => 08188096 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'Protein kinase targeted therapeutics' [patent_app_type] => utility [patent_app_number] => 13/034411 [patent_app_country] => US [patent_app_date] => 2011-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8620 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188096.pdf [firstpage_image] =>[orig_patent_app_number] => 13034411 [rel_patent_id] =>[rel_patent_doc_number] =>)